XBRANE.ST Gross Margin
As of 2025-07-12, the Gross Margin of Xbrane Biopharma AB (XBRANE.ST) is 90.8%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
XBRANE.ST Gross Margin - Historical Value
| Date | Value |
|---|---|
| 2024-12-31 | 90.8% |
| 2023-12-31 | 14.8% |
| 2022-12-31 | - |
| 2021-12-31 | - |
| 2020-12-31 | - |
| 2019-12-31 | - |
| 2018-12-31 | 22.3% |
| 2017-12-31 | 23.8% |
| 2016-12-31 | - |
| 2015-12-31 | -1653.6% |
XBRANE.ST Gross Margin - Peers Comparison